FinanceCity
DiversifiedNSE · BSE

Hikal Ltd.

HIKAL · ISIN INE475B01022

Share price

₹190 +1.37%

Market capitalisation

₹2340 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹2340 Cr

Current price

₹190

+1.37% today

52W high

₹382

52W low

₹146

Stock P/E

P/B ratio

1.95

02 · Per share & returns

EPS (TTM)

-₹3.95

Book value

₹97.40

ROE

ROA

Dividend yield

0.53%

Beta

03 · Financials (TTM)

By the numbers

Revenue

₹1204 Cr

+37.30% YoY

EBITDA

₹224 Cr

Net profit

₹74.02 Cr

+68.30% YoY

Profit margin

6.15%

Operating margin

13.16%

Total debt

Total cash

Debt / equity

Current ratio

Payout ratio

172.84%

04 · Analyst view

Target price

₹300

Upside

+58.04%

Consensus

STRONG BUY

Analysts

1

05 · Shareholding pattern

Who owns HIKAL?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
HIKAL
Exchange
NSE · BSE
CIN
ISIN
INE475B01022
BSE code
524735
Sector
Diversified
Industry
Face value
₹2
Listing date
13 Feb 2001
Employees
Headquarters
Navi Mumbai, India

07 · About

What is Hikal Ltd.?

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Hikal Ltd.?+

The Corporate Identity Number for Hikal Ltd. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Hikal Ltd.?+

Promoter and group-holding details for Hikal Ltd. are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Hikal Ltd.?+

Hikal Ltd. (HIKAL) has a market capitalisation of approximately ₹2340 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other diversified listings

Full sector →